(Q51159183)

31 March 2018

title

2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies. (English)

1 reference

31 March 2018

author name string

Manmeet S Ahluwalia

series ordinal

1

1 reference

31 March 2018

publication date

1 February 2011

1 reference

31 March 2018

Expert Review of Anticancer Therapy

published in

1 reference

31 March 2018

volume

11

1 reference

31 March 2018

issue

2

1 reference

31 March 2018

page(s)

161-163

1 reference

31 March 2018

Malignant gliomas in adults

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.227

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.227

Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.227

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.227

A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.227

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.227

Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.227

Medical therapies for meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.227

21 January 2018

Identifiers

DOI

10.1586/ERA.10.227

1 reference

31 March 2018

1 reference

31 March 2018